10E8.4/iMab Bispecific Antibody in HIV-uninfected and HIV-infected Adults

Clinical trial NCT03875209 · COMPLETED

Trial details

NCT number: NCT03875209
Sponsor: David Ho
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

HIV-1-infection

Start date: 2019-04-08
Primary completion: 2022-03-23
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.